NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary Chapter: 6 - Endocrine system 
Notes:

Any drug not listed on the Formulary should be considered Non-Formulary - Not recommended for prescribing
06.04.02 Male sex hormones and antagonists
Gender incongruence in primary care JPC: Bulletin 272: JPC Position Statement:- Gender Identity Services Trans healthcare - ethical topic - GMC

Testosterone and Esters (Sustanon 250®)
(Injection)

 
Formulary

Amber SPAFor hypogonadism in adult males

Amber SCGFor Gender Dysphoria - must only be prescribed on the advice of a specialist centre under shared care arrangements.

 

 

 

Red Triangle Not suitable for peanut allergic patients (contains arachis oil)

 

Entry reviewed: November 2022

BNF BNFc SPC
Shared care guideline - Treatment of gender dysphoria in people assigned female at birth transitioning to a masculine gender identity

Testosterone Enantate
(Injection)

 
Formulary

Amber SPAFor hypogonadism in adult males

Amber SCGFor Gender Dysphoria - must only be prescribed on the advice of a specialist centre under shared care arrangements.

 

Entry reviewed: November 2022

BNF BNFc SPC
Shared care guideline - Treatment of gender dysphoria in people assigned female at birth transitioning to a masculine gender identity

Testosterone gel (Testogel®Tostran® Testim® Testavan®)
(For hypogonadism or gender dysphoria)

 
Formulary

Amber SPAFor hypogonadism in adult males

Amber SCGFor Gender Dysphoria - must only be prescribed on the advice of a specialist centre under shared care arrangements.

 

Entry reviewed: November 2022

BNF BNFc SPC
MHRA DSU Jan 2023: Topical testosterone (Testogel): risk of harm to children following accidental exposure Shared care guideline - Treatment of gender dysphoria in people assigned female at birth transitioning to a masculine gender identity

Testosterone undecanoate (Nebido®)
(Injection)

 
Formulary

Amber SPAFor hypogonadism in adult males

Amber SCGFor Gender Dysphoria - must only be prescribed on the advice of a specialist centre under shared care arrangements.

 

Entry reviewed: November 2022

BNF BNFc SPC
Shared care guideline - Treatment of gender dysphoria in people assigned female at birth transitioning to a masculine gender identity

Testosterone gel (Testogel® / Tostran®)
(For low sexual desire in post-menopausal women)

Amber SPIS
Restricted Drug Restricted

Testosterone Gel (Testogel® / Tostran®) for the treatment for low sexual desire in post-menopausal women:-

  • To be used in accordance with the recommendations included in NICE Guideline 23 i.e. if HRT alone is not effective.
  • GPs may continue therapy after initiation and stabilisation by a specialist (i.e a clinician with expertise in the treatment of the menopause (Defined as a Consultant Endocrinologist/Gynaecologist or a primary care clinician who has relevant experience and is clinically competent to prescribe).
  • GP Fact sheet available to assist GPs in taking over prescribing, including guidance regarding blood monitoring requirements and patient counselling.

Entry reviewed: Nov 2021

 

BNF SPC
Testosterone gel factsheet MHRA DSU Jan 2023: Topical testosterone (Testogel): risk of harm to children following accidental exposure NICE guidance NG 23:- Menopause -Diagnosis and Management
06.04.02 Anti-androgens
Classifications
GREEN
May be initiated in any care setting
Amber SPA
Specialist to advise therapy and provide first 28 days supply, continuation in Primary Care
Amber SPIS
Specialist to initiate and stabilise medicine prior to continuation in Primary Care
SCG
To be prescribed as per Shared Care Guidance. If no SCG in place status reverts to red.
RED
Red medicines are designated as specialist only medicines which should only be prescribed by a specialist, usually within secondary care (either due to the requirement for specialist knowledge, long-term monitoring requirements, or restrictions that mean medicine supplies are only available to hospitals).
DNP
A decision has been made either locally and/or nationally not to routinely commission this preparation. Do not prescribe.
SELF
To be purchased over the counter. May be prescribed for chronic, long term conditions or on admission to hospital if essential.